In pharmacy technology news, the Committee for Medicinal Products for Human Use (CHMP) – the European Medical Agency’s advisory council – has just announced its support of Novartis’ new drug secukinumab, a treatment for moderate-to-severe plaque psoriasis.
The drug, which will be marketed in…

As those in pharmacy technology industry likely know, abuse is a major problem when it comes prescription painkillers. With misuse levels rising parallel to narcotic painkiller sales, federal health regulators have received much pressure to institute new safeguards.1
In response, the Food and…

Those in the field of pharmacy technology realize the vast importance of identifying the underlying causes of diseases.
For pharmaceutical companies to research and develop effective drugs, they must first have an idea of what to address within the human body. Otherwise, creating drugs that…

When you enter a rewarding career in the health care industry, there is a vast amount of personal and professional knowledge you learn quickly on the job.

In a move that may change the industry of pharmacy technology, Royalty Pharma has announced a $3.3 billion acquisition of royalties on Vertex Pharmaceuticals’ cystic fibrosis treatments owned by an affiliate of the Cystic Fibrosis Foundation.1
This is a major payoff for the nonprofit…

In pharmacy technology news, Gilead Sciences Inc. hepatitis C pill Harvoni has been approved by both the Food and Drug Administration and Health Canada. The drug, which was given the thumbs up in early October 2014 by the FDA, is the first combination pill approved to treat chronic HCV…

November is officially National Alzheimer’s Disease Awareness Month, a time that not only focuses on the 5 million or so Americans that suffer from Alzheimer’s disease, but also pays respect to their devoted caregivers. Alzheimer’s is a monumental health problem in the U.S.- someone in the…